Dow Down 0.13% Nasdaq Up 0.14%

Impax Laboratories Inc. (IPXL)

-NasdaqGS
31.42 Down 0.05(0.16%) Jul 29, 4:00PM EDT
|After Hours : 31.41 Down 0.01 (0.02%) Jul 29, 4:46PM EDT
Prev Close:31.47
Open:31.39
Bid:30.81 x 100
Ask:N/A
1y Target Est:34.86
Beta:1.25487
Next Earnings Date: 9-Aug-16IPXL Earnings announcement
Day's Range:30.63 - 31.51
52wk Range:27.62 - 49.59
Volume:493,152
Avg Vol (3m):656,881
Market Cap:2.32B
P/E (ttm):66.01
EPS (ttm):0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IPXLDown 0.16%2.32B
MYLUp 0.15%23.79B

Key Statistics

Forward P/E (1 yr):12.32
P/S (ttm):2.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :1.77
Quarterly EPS Est (Jun-16) :0.32
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Impax Generics and Impax Specialty Pharma. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback